Literature DB >> 17371801

Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and function.

Jason M Walraven1, John O Trent, David W Hein.   

Abstract

Arylamine N-acetyltransferases (NATs) play an important role in the metabolism of arylamine and hydrazine drugs and many arylamine procarcinogens. The two human N-acetyltransferases, NAT1 and NAT2, are widely distributed in human tissues and are highly polymorphic. Although many xenobiotic procarcinogens and drugs are known mammalian NAT substrates, it is unclear what physiological roles these enzymes might play, what endogenous substrates they primarily act upon, or the mechanisms underlying the functional effects of specific NAT gene coding region single-nucleotide polymorphisms. Analyses of mammalian NAT protein structures can greatly help to answer these questions. Homology modeling techniques can be used to approximate mammalian NAT structures using known bacterial NAT crystal structures as templates. In comparison to the bacterial template NATs used for homology modeling, mammalian NATs have a 17-residue insert of unknown structure and function. Homology modeling analyses yielded two different alignments (Modeler 8v1 or 3DCoffee algorithms) that placed this insert in two likely alternative locations. Secondary structure prediction techniques and experimental analyses of a series of human NAT2 mutants with artificial deletions/replacements of the insert region distinguished one of these alternatives as the most likely insert location and provided a better understanding of its structure and function. This study demonstrates both the utility and limitations of computational structural modeling with proteins that differ as much as the mammalian and bacterial NATs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371801      PMCID: PMC2085365          DOI: 10.1124/dmd.107.015040

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  39 in total

1.  Application of multiple sequence alignment profiles to improve protein secondary structure prediction.

Authors:  J A Cuff; G J Barton
Journal:  Proteins       Date:  2000-08-15

2.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

Review 3.  Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.

Authors:  D W Hein; M A Doll; A J Fretland; M A Leff; S J Webb; G H Xiao; U S Devanaboyina; N A Nangju; Y Feng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-01       Impact factor: 4.254

4.  Insights into the o-acetylation reaction of hydroxylated heterocyclic amines by human arylamine N-acetyltransferases: a computational study.

Authors:  Edmond Y Lau; James S Felton; Felice C Lightstone
Journal:  Chem Res Toxicol       Date:  2006-09       Impact factor: 3.739

5.  A rapid and convenient method for the preparation and storage of competent bacterial cells.

Authors:  C T Chung; R H Miller
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

Review 6.  N-acetylation pharmacogenetics.

Authors:  W W Weber; D W Hein
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

7.  Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.

Authors:  Jason M Walraven; Mark A Doll; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2006-07-07       Impact factor: 4.030

8.  Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.

Authors:  David F Barker; Anwar Husain; Jason R Neale; Benjamin D Martini; Xiaoyan Zhang; Mark A Doll; J Christopher States; David W Hein
Journal:  Pharmacogenet Genomics       Date:  2006-07       Impact factor: 2.089

9.  Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues.

Authors:  Anwar Husain; Xiaoyan Zhang; Mark A Doll; J Christopher States; David F Barker; David W Hein
Journal:  Drug Metab Dispos       Date:  2007-02-07       Impact factor: 3.922

Review 10.  Acetylator genotype and arylamine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Biochim Biophys Acta       Date:  1988-08-03
View more
  9 in total

Review 1.  Arylamine N-acetyltransferases: a structural perspective.

Authors:  Xiaotong Zhou; Zhiguo Ma; Dong Dong; Baojian Wu
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 2.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.

Authors:  Jason M Walraven; Yu Zang; John O Trent; David W Hein
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

Review 3.  N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine.

Authors:  David W Hein
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-04       Impact factor: 4.481

Review 4.  Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1.

Authors:  Jason M Walraven; John O Trent; David W Hein
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

5.  PtmC Catalyzes the Final Step of Thioplatensimycin, Thioplatencin, and Thioplatensilin Biosynthesis and Expands the Scope of Arylamine N-Acetyltransferases.

Authors:  Cheng-Jian Zheng; Edward Kalkreuter; Bo-Yi Fan; Yu-Chen Liu; Liao-Bin Dong; Ben Shen
Journal:  ACS Chem Biol       Date:  2020-12-14       Impact factor: 5.100

6.  Effects of single nucleotide polymorphisms on human N-acetyltransferase 2 structure and dynamics by molecular dynamics simulation.

Authors:  M Rajasekaran; Santhanam Abirami; Chinpan Chen
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

Review 7.  Arylamine N-acetyltransferases in mycobacteria.

Authors:  Edith Sim; James Sandy; Dimitrios Evangelopoulos; Elizabeth Fullam; Sanjib Bhakta; Isaac Westwood; Anna Krylova; Nathan Lack; Martin Noble
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

8.  Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.

Authors:  Alice Matimba; Jurgen Del-Favero; Christine Van Broeckhoven; Collen Masimirembwa
Journal:  Hum Genomics       Date:  2009-01       Impact factor: 4.639

9.  Rapid birth-and-death evolution of the xenobiotic metabolizing NAT gene family in vertebrates with evidence of adaptive selection.

Authors:  Audrey Sabbagh; Julie Marin; Charlotte Veyssière; Emilie Lecompte; Sotiria Boukouvala; Estella S Poloni; Pierre Darlu; Brigitte Crouau-Roy
Journal:  BMC Evol Biol       Date:  2013-03-07       Impact factor: 3.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.